Hasengaowa

405 total citations
11 papers, 340 citations indexed

About

Hasengaowa is a scholar working on Cell Biology, Molecular Biology and Oncology. According to data from OpenAlex, Hasengaowa has authored 11 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cell Biology, 7 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Hasengaowa's work include Proteoglycans and glycosaminoglycans research (7 papers), Glycosylation and Glycoproteins Research (4 papers) and Fibroblast Growth Factor Research (4 papers). Hasengaowa is often cited by papers focused on Proteoglycans and glycosaminoglycans research (7 papers), Glycosylation and Glycoproteins Research (4 papers) and Fibroblast Growth Factor Research (4 papers). Hasengaowa collaborates with scholars based in Japan, China and United States. Hasengaowa's co-authors include Junichi Kodama, Tamon Kusumoto, Narihito Seki, Yoshihiro Hiramatsu, Ayumi Hongo, Toshihiko Matsuo, Kazufumi Nakamura, Y Hiramatsu, Yuji Hiramatsu and Tomoyuki Kusumoto and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Gynecologic Oncology.

In The Last Decade

Hasengaowa

11 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hasengaowa Japan 9 180 134 125 95 67 11 340
Kirsi Voutilainen Finland 6 211 1.2× 137 1.0× 108 0.9× 58 0.6× 106 1.6× 7 362
Chery A. Whipple United States 8 229 1.3× 163 1.2× 102 0.8× 101 1.1× 100 1.5× 10 396
Feng-Qiang Wang United States 6 205 1.1× 100 0.7× 48 0.4× 66 0.7× 128 1.9× 7 350
Claudia Knoll Germany 5 199 1.1× 192 1.4× 40 0.3× 57 0.6× 57 0.9× 5 377
Hua Linghu China 13 251 1.4× 105 0.8× 54 0.4× 61 0.6× 91 1.4× 34 415
Jane Cipollone Canada 7 138 0.8× 95 0.7× 45 0.4× 43 0.5× 49 0.7× 8 284
Olga Tatti Finland 6 158 0.9× 142 1.1× 66 0.5× 28 0.3× 141 2.1× 6 345
Lisa Lock Canada 5 319 1.8× 80 0.6× 58 0.5× 55 0.6× 36 0.5× 5 405
Katrin L. Gutbrodt Switzerland 9 236 1.3× 163 1.2× 97 0.8× 86 0.9× 74 1.1× 10 407
María Giselle Peters Argentina 10 300 1.7× 177 1.3× 120 1.0× 43 0.5× 89 1.3× 17 469

Countries citing papers authored by Hasengaowa

Since Specialization
Citations

This map shows the geographic impact of Hasengaowa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hasengaowa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hasengaowa more than expected).

Fields of papers citing papers by Hasengaowa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hasengaowa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hasengaowa. The network helps show where Hasengaowa may publish in the future.

Co-authorship network of co-authors of Hasengaowa

This figure shows the co-authorship network connecting the top 25 collaborators of Hasengaowa. A scholar is included among the top collaborators of Hasengaowa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hasengaowa. Hasengaowa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hasengaowa, Guiping Zhang, Ming Li, et al.. (2015). Profiling of miRNA expression in immune thrombocytopenia patients before and after Qishunbaolier (QSBLE) treatment. Biomedicine & Pharmacotherapy. 75. 196–204. 15 indexed citations
2.
Kodama, Junichi, Hasengaowa, Tamon Kusumoto, et al.. (2007). Versican expression in human cervical cancer. European Journal of Cancer. 43(9). 1460–1466. 30 indexed citations
3.
Kodama, Junichi, Hasengaowa, Naoko Seki, Tamon Kusumoto, & Y Hiramatsu. (2007). Expression of the CXCR4 and CCR7 chemokine receptors in human endometrial cancer.. PubMed. 28(5). 370–5. 20 indexed citations
4.
Kodama, Junichi, Hasengaowa, Tamon Kusumoto, et al.. (2006). Prognostic significance of stromal versican expression in human endometrial cancer. Annals of Oncology. 18(2). 269–274. 56 indexed citations
5.
Kodama, Junichi, Hasengaowa, Tamon Kusumoto, et al.. (2006). Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer. Annals of Oncology. 18(1). 70–76. 109 indexed citations
6.
Hasengaowa, Junichi Kodama, Tamon Kusumoto, et al.. (2006). Heparanase expression in both normal endometrium and endometrial cancer. International Journal of Gynecological Cancer. 16(3). 1401–1406. 7 indexed citations
7.
Kodama, Junichi, Hasengaowa, Tomoyuki Kusumoto, et al.. (2005). Loss of basement membrane heparan sulfate expression is associated with pelvic lymph node metastasis in invasive cervical cancer.. PubMed. 14(1). 89–92. 15 indexed citations
8.
Hasengaowa, et al.. (2005). Prognostic significance of syndecan-1 expression in human endometrial cancer. Annals of Oncology. 16(7). 1109–1115. 34 indexed citations
9.
Kodama, Junichi, Hasengaowa, Tomoyuki Kusumoto, et al.. (2005). Prognostic significance of the thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio in invasive cervical cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 121(1). 81–85. 1 indexed citations
10.
Hasengaowa, Junichi Kodama, Tamon Kusumoto, et al.. (2005). Loss of basement membrane heparan sulfate expression is associated with tumor progression in endometrial cancer.. PubMed. 26(4). 403–6. 22 indexed citations
11.
Kodama, Junichi, et al.. (2004). Loss of cell-surface heparan sulfate expression in both cervical intraepithelial neoplasm and invasive cervical cancer. Gynecologic Oncology. 96(3). 776–783. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026